Senate HELP Chairman Bernie Sanders launches another salvo in drug pricing war, this one aimed at popular weight loss drugs.

Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.

When government officials and politicians scrutinize high U.S. drug prices, the role of insurers and pharmacy benefit ...

Leading pharmacy benefit managers are reportedly willing to expand coverage for Novo Nordisk’s (NVO) popular diabetes and ...

The PBMs say out-of-pocket insulin costs have fallen sharply since 2019. The Pharmaceutical Care Management Association, ...

California lawmakers have sent a bill to Gov. Gavin Newsom that aims to rein in the PBMs they say drive up costs and limit ...

Novo Nordisk's CEO faced lawmakers in a grueling 2.5-hour hearing to discuss the cost of blockbuster drugs Ozempic and Wegovy ...

The government’s antitrust watchdog on Friday sued three massive health conglomerates, accusing their drug middlemen of ...

No, if Novo Nordisk lowered their list price for Ozempic and Wegovy tomorrow to a price that was the same or lower than current net cost, that change by itself would not result in less favorable ...

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...

U.S. Senator Bernie Sanders announced that pharmacy benefit managers have agreed to expand coverage for Novo Nordisk's ...

The city of Baltimore's lawsuit contended Biogen paid the companies to “manipulate” placement of generic versions of ...